Rhenman & Partners Asset Management Ab ALEXION PHARMACEUTICALS INC Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	N/A	-40,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	N/A	-80,000 Reduced 66.67%	40,000 $6.12 Million
Q4 2020 Jan 19, 2021	SELL	N/A	-100,000 Reduced 45.45%	120,000 $18.7 Million
Q3 2020 Oct 13, 2020	BUY	N/A	30,000 Added 15.79%	220,000 $25.2 Million
Q2 2020 Jul 16, 2020	BUY	N/A	30,000 Added 18.75%	190,000 $21.3 Million
Q1 2020 Apr 16, 2020	BUY	N/A	18,681 Added 13.22%	160,000 $14.4 Million
Q4 2019 Jan 17, 2020	SELL	N/A	-105,984 Reduced 42.86%	141,319 $15.3 Million
Q3 2019 Oct 16, 2019	BUY	N/A	44,286 Added 21.81%	247,303 $24.2 Million
Q2 2019 Jul 22, 2019	BUY	N/A	66,551 Added 48.77%	203,017 $26.6 Million
Q1 2019 Apr 11, 2019	SELL	N/A	-93,963 Reduced 40.78%	136,466 $18.4 Million
Q4 2018 Feb 05, 2019	SELL	N/A	-12,900 Reduced 5.3%	230,429 $22.4 Million
Q3 2018 Oct 03, 2018	BUY	N/A	51,466 Added 26.82%	243,329 $33.8 Million
Q2 2018 Jul 20, 2018	SELL	N/A	-30,000 Reduced 13.52%	191,863 $23.8 Million
Q1 2018 Apr 11, 2018	BUY	N/A	70,000 Added 46.09%	221,863 $24.7 Million
Q4 2017 Jan 19, 2018	SELL	N/A	-13,137 Reduced 7.96%	151,863 $18.2 Million
Q3 2017 Oct 13, 2017	BUY	N/A	165,000	165,000 $23.1 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.